The Effect of 360° Virtual Reality Movies on Fear and Anxiety (ENGAGE)

M

Maastricht Radiation Oncology

Status

Enrolling

Conditions

Fear
Breast Cancer
Brain Tumor
Lung Cancer
Head and Neck Cancer
Anxiety
Prostate Cancer

Treatments

Other: Questionnaire: QSC-R23
Other: Clinical data collected
Other: Questionnaire: HADS
Other: General questions
Other: Questionnaire: SPIRIT

Study type

Interventional

Funder types

Other

Identifiers

NCT06199050
ENGAGE

Details and patient eligibility

About

To assess the effect of web-based 360° Virtual Reality movies on fear and anxiety, The investigators would like to assess the patient-perceived level of fear and anxiety quantitatively, making use of several questionnaires.

Full description

In ENGAGE, a KWF Samenloop Voor Hoop subsidized project, we have developed VR movies to reduce fear and anxiety for patients who are going to be treated at Maastro. These movies are based on where most fear and anxiety are experienced and have been developed after extensive discussion with different disciplines in patient care and with agreement of the Director Patient Care. The movies include: 1) Mouldroom, 2) VMDIBH mamma photons, 3) Head and Neck photons, 4) Lung photons, 5) CT-scan, 6) Prostate photons, and 7) Head and Neck/ Neuro protons. Currently, the web-based 360° movies are implemented in clinical practice and the VR glasses with the 360° movies will be used as soon as social work has decided on where to integrate the use in the care pathway.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with breast- (only VMDIP), lung-, prostate-, head and neck cancer, a brain tumor.
  • Age 18+
  • Being able to speak, read and write in Dutch
  • General interview between radiation oncologist and patient (= Intake)
  • Ability to give written informed consent before the start of the study
  • Decision talk about start of treatment must have taken place

Exclusion criteria

  • Patients who are already receiving radiotherapy treatment
  • Pre-operative consultation for breast cancer patients
  • Patients who have seen the VR-videos already

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

600 participants in 2 patient groups

360° Virtual Reality Movies
Experimental group
Description:
assess the amount of fear, anxiety and stress by using specific questionnaires: SPecifIc RadIation Treatment related questions (SPIRIT) Hospital Anxiety and Depression Scale (HADS) Dutch version of the Questionnaire on stress symptoms (QSC-R23) General questions: Education level Marietal status Medication use (in order to assess influence on fear) Previous cancer diagnosis Acquired information on treatment Expected fear and anxiety mitigation strategies Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) PROM at baseline Clinical data: Age Gender Cancer type WHO status TNM
Treatment:
Other: Questionnaire: SPIRIT
Other: General questions
Other: Questionnaire: HADS
Other: Clinical data collected
Other: Questionnaire: QSC-R23
Group without intervention
Experimental group
Description:
In a measurement over 5 months without any intervention the investigators have assessed the amount of fear, anxiety and stress by using a specific subjective questionnaire on the items below: assess the amount of fear, anxiety and stress by using specific questionnaires: SPecifIc RadIation Treatment related questions (SPIRIT) Hospital Anxiety and Depression Scale (HADS) Dutch version of the Questionnaire on stress symptoms (QSC-R23) General questions: Education level Marietal status Medication use (in order to assess influence on fear) Previous cancer diagnosis Acquired information on treatment Expected fear and anxiety mitigation strategies Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) PROM at baseline Clinical data: Age Gender Cancer type WHO status TNM
Treatment:
Other: Questionnaire: SPIRIT
Other: General questions
Other: Questionnaire: HADS
Other: Clinical data collected
Other: Questionnaire: QSC-R23

Trial contacts and locations

1

Loading...

Central trial contact

Chiara Coleman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems